162 related articles for article (PubMed ID: 11675351)
21. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
23. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines.
Weber-Nordt RM; Egen C; Wehinger J; Ludwig W; Gouilleux-Gruart V; Mertelsmann R; Finke J
Blood; 1996 Aug; 88(3):809-16. PubMed ID: 8704235
[TBL] [Abstract][Full Text] [Related]
24. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-9 (IL-9) induces cell growth arrest associated with sustained signal transducer and activator of transcription activation in lymphoma cells overexpressing the IL-9 receptor.
Demoulin JB; Van Snick J; Renauld JC
Cell Growth Differ; 2001 Mar; 12(3):169-74. PubMed ID: 11306517
[TBL] [Abstract][Full Text] [Related]
26. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells.
Matikainen S; Sareneva T; Ronni T; Lehtonen A; Koskinen PJ; Julkunen I
Blood; 1999 Mar; 93(6):1980-91. PubMed ID: 10068671
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model.
Tun-Kyi A; Qin JZ; Oberholzer PA; Navarini AA; Hassel JC; Dummer R; Döbbeling U
Ann Oncol; 2008 Aug; 19(8):1488-1494. PubMed ID: 18349030
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expression.
Masuda A; Matsuguchi T; Yamaki K; Hayakawa T; Yoshikai Y
J Biol Chem; 2001 Jul; 276(28):26107-13. PubMed ID: 11369758
[TBL] [Abstract][Full Text] [Related]
29. Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma.
Sibbesen NA; Kopp KL; Litvinov IV; Jønson L; Willerslev-Olsen A; Fredholm S; Petersen DL; Nastasi C; Krejsgaard T; Lindahl LM; Gniadecki R; Mongan NP; Sasseville D; Wasik MA; Iversen L; Bonefeld CM; Geisler C; Woetmann A; Odum N
Oncotarget; 2015 Aug; 6(24):20555-69. PubMed ID: 26244872
[TBL] [Abstract][Full Text] [Related]
30. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A
Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399
[TBL] [Abstract][Full Text] [Related]
31. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells.
Döbbeling U; Dummer R; Laine E; Potoczna N; Qin JZ; Burg G
Blood; 1998 Jul; 92(1):252-8. PubMed ID: 9639524
[TBL] [Abstract][Full Text] [Related]
33. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
Wang Y; Gu X; Li W; Zhang Q; Zhang C
J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
[TBL] [Abstract][Full Text] [Related]
34. Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.
Chen J; Fiskus W; Eaton K; Fernandez P; Wang Y; Rao R; Lee P; Joshi R; Yang Y; Kolhe R; Balusu R; Chappa P; Natarajan K; Jillella A; Atadja P; Bhalla KN
Blood; 2009 Apr; 113(17):4038-48. PubMed ID: 19074726
[TBL] [Abstract][Full Text] [Related]
35. A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.
Heckman CA; Mehew JW; Ying GG; Introna M; Golay J; Boxer LM
J Biol Chem; 2000 Mar; 275(9):6499-508. PubMed ID: 10692454
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
Marzec M; Halasa K; Kasprzycka M; Wysocka M; Liu X; Tobias JW; Baldwin D; Zhang Q; Odum N; Rook AH; Wasik MA
Cancer Res; 2008 Feb; 68(4):1083-91. PubMed ID: 18281483
[TBL] [Abstract][Full Text] [Related]
37. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
Timblin GA; Schlissel MS
J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
[TBL] [Abstract][Full Text] [Related]
38. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
Zhang C; Li B; Gaikwad AS; Haridas V; Xu Z; Gutterman JU; Duvic M
J Invest Dermatol; 2008 Nov; 128(11):2728-2735. PubMed ID: 18496567
[TBL] [Abstract][Full Text] [Related]
39. Thrombopoietin regulates Bcl-xL gene expression through Stat5 and phosphatidylinositol 3-kinase activation pathways.
Kirito K; Watanabe T; Sawada K; Endo H; Ozawa K; Komatsu N
J Biol Chem; 2002 Mar; 277(10):8329-37. PubMed ID: 11756417
[TBL] [Abstract][Full Text] [Related]
40. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]